tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Adma Biologics options imply 14.3% move in share price post-earnings
PremiumThe FlyAdma Biologics options imply 14.3% move in share price post-earnings
26d ago
Adma Biologics management to meet virtually with Cantor
Premium
The Fly
Adma Biologics management to meet virtually with Cantor
28d ago
Adma Biologics management to meet virtually with Cantor
Premium
The Fly
Adma Biologics management to meet virtually with Cantor
28d ago
ADMA Biologics Secures $300M Credit Agreement with JPMorgan
PremiumCompany AnnouncementsADMA Biologics Secures $300M Credit Agreement with JPMorgan
4M ago
Adma Biologics reports Q2 EPS 14c, consensus 14c
Premium
The Fly
Adma Biologics reports Q2 EPS 14c, consensus 14c
4M ago
Adma Biologics affirms 2025 revenue outlook over $500M, consensus $505.83M
Premium
The Fly
Adma Biologics affirms 2025 revenue outlook over $500M, consensus $505.83M
4M ago
ADMA Biologics Reports Strong Growth and Strategic Advances
PremiumCompany AnnouncementsADMA Biologics Reports Strong Growth and Strategic Advances
7M ago
Adma Biologics price target raised to $32 from $25 at Raymond James
Premium
The Fly
Adma Biologics price target raised to $32 from $25 at Raymond James
7M ago
ADMA Biologics Reports Strong Q1 2025 Financial Growth
Premium
Company Announcements
ADMA Biologics Reports Strong Q1 2025 Financial Growth
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100